Energy-Based Vaginal Devices: What the Regulators Have Actually Said

What regulators actually say about vaginal rejuvenation devices

The term vaginal rejuvenation is not a medical diagnosis. It's a marketing phrase that's been slapped onto a range of energy-based treatments, from fractional CO2 lasers to radiofrequency and focused ultrasound. Regulators have noticed. The Australian Therapeutic Goods Administration (TGA) completed a post-market review of all energy-based devices used for vaginal rejuvenation that were included in the Australian Register of Therapeutic Goods (ARTG). The review found insufficient clinical evidence to support the therapeutic use and long-term safety of these devices. That is not a minor wording issue. It's a formal finding by a national regulator after examining the submitted clinical data.

Following that review, every energy-based device intended for vaginal rejuvenation sold in Australia was cancelled from the ARTG, either by the TGA or by the sponsor. Today, there are no devices included in the ARTG that are approved for use for vaginal rejuvenation. None. If you operate in Australia, or if you export to Australia, that single sentence should stop you cold. It means you cannot lawfully supply a device for that indication in that market, no matter what the manufacturer's brochure says. The TGA review covered radiofrequency, carbon dioxide, and Er:YAG laser devices. It did not matter whether the energy source was heat, light, or sound. The evidence was not there.

The United States Food and Drug Administration took a similar line. In July 2018, the FDA published a statement on the risks related to devices marketed for vaginal rejuvenation. The agency said it had “serious concerns about the use of these devices to treat gynecological conditions beyond those for which the devices have been approved or cleared.” The FDA also warned that safety and effectiveness had not been established for vaginal “rejuvenation” or aesthetic genitourinary applications. That warning is still in force. If you buy a device with a vaginal handpiece in the US, you're buying an uncleared indication. You may be able to use the device for its cleared indication, such as general surgical cutting or coagulation, but you cannot market it for vaginal tightening without breaking federal law.

The United Kingdom's Medicines and Healthcare products Regulatory Agency (MHRA) makes a subtler but equally important point. Registration of a medical device with the MHRA does not represent any form of accreditation, certification, approval or endorsement by the MHRA. That sentence belongs on your wall. Buyers routinely confuse registration with approval. Registration just means the device is on a list. It says nothing about whether the device works for a given indication. When a distributor tells you a vaginal tightening machine is “registered” or “CE marked”, ask what exactly that mark covers. Usually it covers the device's electrical safety and basic performance, not a clinical claim about vaginal tissue remodeling.

Adverse effects that show up in the real world

Energy-based vaginal treatments are not harmless. The FDA's MAUDE database of adverse event reports includes one entry for a Viveve Genevieve laser that lists fatigue, incontinence, pain, dizziness, and “lost all feeling in my vagina including the urge or.” That's a patient's own wording in a mandatory report. It should be required reading for any clinic owner who thinks a vaginal cartridge is just another upsell. The report doesn't prove causation. It does prove that serious adverse events are being reported to the agency, and that the agency is watching. When you hold a device that delivers radiofrequency or focused ultrasound to delicate mucosal tissue, you're responsible for every Joule that goes in. If you can't explain the depth of penetration, the thermal profile, and the cooling mechanism to a patient in plain language, you aren't ready to offer the treatment.

Screening isn't optional. Patients with active infection, undiagnosed abnormal bleeding, pregnancy, recent childbirth, or a history of pelvic radiation shouldn't be treated without specialist clearance. You need a formal consent process that states the regulatory status of the device for this indication in your market. A generic laser consent form will not survive a complaint. The consent must say, in writing, that the treatment is off-label or unapproved for vaginal tightening, that long-term safety data are lacking, and that alternatives such as pelvic floor physiotherapy exist. If that scares off a patient, good. That patient was not a candidate for an experimental indication.

Why a handpiece in a catalogue is not an approved indication

Our own HIFU platform, the HF-01 focused ultrasound system, lists a vaginal cartridge as an optional accessory. That is a mechanical fact. It means the cartridge physically connects to the handpiece and the software recognizes it. It does not mean the device is approved to treat vaginal laxity, stress urinary incontinence, or any other gynecological condition. We make no therapeutic claim for that cartridge. None. If you buy an HF-01 with the vaginal cartridge, you're buying a piece of hardware. The regulatory question is entirely yours. Different markets have different rules, and those rules change. A distributor in one country may tell you the cartridge is “cleared” because the base device has a CE mark. That is legally meaningless. A CE mark is not an indication-specific approval.

Ask the manufacturer for the device's intended use statement. Every medical device has one. It's a short paragraph written by the manufacturer and reviewed by the regulator where applicable. For most energy-based platforms, the intended use will say something like “for general surgical procedures requiring ablation, coagulation, or resection of soft tissue.” That's the cleared indication. Vaginal tightening is not in that paragraph. If a sales rep shows you a brochure with vaginal rejuvenation images, ask where that indication appears in the regulatory approval. If the answer is vague, walk away. You're buying the legal liability, not the manufacturer. The manufacturer is in Beijing. You're in front of the patient.

Who may legally perform such a treatment also varies. In many jurisdictions, only a licensed physician may operate an energy-based device for gynecological use. In others, a nurse practitioner or a physician assistant may do so under delegation. Some markets prohibit non-physicians from using any laser or radiofrequency device, regardless of indication. Check your local medical board rules before you let anyone touch the handpiece. A device that's sold as “safe for aestheticians” in one country may be a criminal offense in another. The device doesn't know where it is. You do.

What you can actually do as a responsible buyer

First, separate the device from the claim. You can buy a high-quality radiofrequency or HIFU platform for legitimate indications: skin tightening on the face, body contouring, scar revision. Those indications have clinical evidence and regulatory clearance in many markets. Buy the platform for those uses. If the vaginal cartridge is included, park it until your market has clear guidance. Don't build a marketing campaign around an uncleared indication. That's how clinics get warning letters.

Second, audit your supplier. The company should be certified to ISO 13485, the medical device quality management standard. It should be able to show you the device's Declaration of Conformity and the exact scope of any CE mark. Our own engineering archive confirms that we operate under ISO 9001, ISO 13485, and CE 93/42/EEC certification for our manufacturing facility in Beijing. That certification covers the quality system, not a vaginal tightening claim. A supplier who won't share regulatory documents is hiding something.

Third, build a consent and screening protocol before you advertise anything. Your protocol should include a medical history form that screens for contraindications, a cooling-off period between consultation and treatment, and a written consent that names the specific device and cartridge, states the regulatory status in your country, and lists all known adverse effects from the manufacturer's instructions for use. If the manufacturer's instructions for use do not include vaginal use, stop. You're now using the device outside its intended purpose. That changes your liability completely.

Fourth, know your market. The TGA position is the strictest: no ARTG inclusion for vaginal rejuvenation devices. The FDA position is that safety and effectiveness have not been established for this indication. The MHRA position is that registration is not approval. If you operate in the European Union under the Medical Device Regulation, you need to check whether any notified body has issued a certificate for a vaginal tightening indication. Most have not. If a distributor claims a device is “MDR approved for vaginal rejuvenation”, ask for the certificate number and check it on the European database. In my experience, that certificate doesn't exist.

What about the patients who ask for it?

Patients ask for vaginal tightening because they've seen it on social media or because a friend had a treatment overseas. They don't know the regulatory history. They don't know that the TGA cancelled every such device from the Australian register. They don't know that the FDA found no established safety or effectiveness. Your job isn't to sell them a machine. It's to give them accurate information and let them decide. That often means telling them that the evidence is thin, that the long-term risks are unknown, and that a pelvic floor physiotherapist might be a better first step. If you lose the sale, you keep your reputation.

If you do offer energy-based vaginal treatment in a market where it's permitted, you carry a heavier burden. You need to document baseline symptoms, set realistic expectations, and follow up at defined intervals. You need to report adverse events to your national regulator, even if you're not legally required to do so. The FDA's MAUDE database exists because clinicians and manufacturers report. If you see a patient with numbness, pain, or altered sensation after a vaginal treatment, report it. That's how the evidence base grows. Right now, the evidence base is small enough that regulators have banned the indication in at least one country. Don't be the clinic that adds to the adverse event list without adding to the evidence.

Checklist before you buy any vaginal tightening machine

• Request the device's intended use statement from the manufacturer. Does it mention vaginal rejuvenation or vaginal tightening? If yes, ask for the regulatory approval number for that indication.
• Check the TGA ARTG database if you're in Australia. There are currently no devices approved for vaginal rejuvenation. If a supplier says otherwise, they're wrong.
• Review the FDA's July 2018 statement and the FDA warning. If your market is the US, understand that marketing for vaginal rejuvenation is an off-label promotion.
• Ask about the CE mark scope. A CE mark for the base device does not cover an uncleared gynecological indication.
• Read the manufacturer's instructions for use cover to cover. Look for any mention of vaginal use. If absent, the device is not intended for that use.
• Check your local regulations on who may operate energy-based devices on mucosal tissue. In many places, only a physician may do so.
• Develop a specific consent form for vaginal treatments that includes the regulatory status, known risks, and alternatives. Have a lawyer review it.
• Establish a screening protocol for contraindications: pregnancy, infection, abnormal bleeding, recent childbirth, pelvic radiation.
• Plan for adverse event reporting. Know your national regulator's reporting portal and use it.
• Never buy a device solely on a distributor's claim of “FDA cleared” or “CE approved” for vaginal tightening. Verify the specific indication in writing.

If you do all that, you'll be in a small minority of buyers. Most clinics buy a multi-platform device because it has a vaginal cartridge and they think it's an easy add-on. It isn't. It's a regulatory minefield. The smartest buyers treat the vaginal cartridge as a research tool, not a revenue stream. If you want to explore the technology, do it in collaboration with a hospital ethics committee and a proper clinical trial. That's how the evidence base will eventually grow. Until then, buy for the cleared indications. There are plenty.

FAQ: Vaginal tightening machines and the law

Is a vaginal tightening machine approved by the FDA?

No. The FDA has stated that safety and effectiveness have not been established for vaginal rejuvenation or aesthetic genitourinary applications. The agency has serious concerns about the use of these devices for gynecological conditions beyond those for which they have been approved or cleared. Any device marketed for vaginal tightening in the US is being marketed off-label unless it has a specific cleared indication for that use, which currently doesn't exist.

What did the TGA find in its review?

The TGA found insufficient clinical evidence to support the therapeutic use and long-term safety of energy-based devices for vaginal rejuvenation. The review covered radiofrequency, CO2 laser, and Er:YAG laser devices. As a result, all such devices were cancelled from the Australian Register of Therapeutic Goods. There are now no devices approved for vaginal rejuvenation in Australia.

Can a non-physician operate a vaginal tightening machine?

In most regulated markets, no. Energy-based devices that deliver radiofrequency, laser, or focused ultrasound to mucosal tissue are generally restricted to licensed physicians. Some jurisdictions allow nurse practitioners or physician assistants under direct supervision, but the trend is toward physician-only operation for gynecological applications. Check your local medical board rules before allowing any non-physician to use the device.

Does our HIFU platform's vaginal cartridge have regulatory approval?

No. The HF-01 focused ultrasound system is a general surgical device. The vaginal cartridge is an optional accessory that fits the handpiece. We make no therapeutic claim for that cartridge. The regulatory status of using it for vaginal tightening varies by market, and in many markets it would be considered off-label or unapproved. Buyers must confirm the position in their own market before advertising any vaginal indication.

This page is educational material for equipment buyers. It is not medical advice. Diagnosis and treatment decisions belong to licensed healthcare professionals, and regulatory requirements vary by jurisdiction. For more on device technologies, see our complete guide library. For service and support on any Pmise platform, visit our service centre.

Evidence and further reading

Educational material for equipment buyers and operators. It is not medical advice, an operating protocol or a promise of clinical outcome.

• Post-market review of energy-based devices used for vaginal rejuvenation | Therapeutic Goods Administration (TGA)
• Medicines and Healthcare products Regulatory Agency - PARD
• MAUDE Adverse Event Report: VIVEVE GENEVIEVE LASER